AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Evaluation of Patient-Reported Outcomes Measurement Information System (PROMIS)-29 v2.1 for Postpartum Women

Recruitingn/aAges 18 Years - 55 YearsFemaleSamuel Lunenfeld Research Institute, Mount Sinai โ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

There is no widely used, statistically validated assessment for physical and mental health for the short- to medium-term in a postpartum population. PROMIS-29 has been validated for the assessment of these factors in a generic population, but has not been specifically evaluated for use with postpartum women. This study is a longitudinal, single center observational cohort study designed to evaluate the reliability of the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 v2.1 survey in a postpartum population. PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living. While this survey has shown utility in other populations, it has yet to be assessed in an obstetric population. The investigators plan to recruit patients who are recently postpartum from vaginal or cesarean delivery to complete virtual surve

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * 18 years old and over * singleton births * 37 or more weeks gestational age * multiparous or nulliparous patients * spontaneous vaginal delivery or scheduled cesarean delivery with labor analgesia or neuraxial anesthesia * give informed written consent Exclusion Criteria: * refusal to take part * are unable to give or have withdrawn consent * patients unable to communicate fluently in English * patients who are less than 18 years old * patients who had fetal demise or severely morbid fetal conditions such as intubation, cooling, expected surgical correction of congenital anomaly during hospitalization (although NICU admissions will be included) * patients who were admitted in ICU * patients who had failed neuraxial analgesia such as replaced epidurals or failed spinal requiring conversion to general anesthesia * patients who had general anesthesia for cesarean delivery as defined by "GETA", including sedatives and deep sedation if not intubated * patients who had intrapartum cesarean or had assisted/operative (i.e. vacuum, forceps) vaginal delivery.
๐Ÿ’Š

What it tests

  • PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System)
  • WHOQoLBREF (World Health Organization Quality of Life Brief Version)
  • EQ-5D-3L1 (not an acronym)
๐Ÿ“

Where

1 site
Mount Sinai Hospital
Toronto, Canada
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy